Health News

Recce Pharmaceuticals’ new class antibiotic effective in treating urinary tract infections during pre-clinical trials – Small Caps

Frequent urinary tract infection (UTI) and kidney infection sufferers may have some relief after Recce Pharmaceuticals (ASX: RCE) revealed pre-clinical trials had demonstrated its new class broad spectrum antibiotics were effective against one of the primary …

Click here to view the original article.

Previous post

CoroCoro Reveals The Silhouette Of The Brand New Mythical Pokémon - Nintendo Life

Next post

A seventh child who contracted a mold infection at Seattle Children's Hospital has died - CNN

Australian Online News

Australian Online News